So far, three human umbilical cord mesenchymal stem cell clinical research projects jointly submitted by SCLnow^® and XiangYa Hospital of Central South University in 2018 and 2019 have been reviewed and successfully filed by the Expert Committees of two national ministries and commission for registration in the National Medical Research Registration Information System. The three projects are:

1, Hepatobiliary surgery - "Human umbilical cord mesenchymal stem cells (19 # iSCLife-LC) treatment for decompensated hepatitis B liver cancer clinical study”

2. Sports Medicine - "Study on the safety and efficacy of human umbilical cord mesenchymal stem cells (19#iSCLife-OA) in the treatment of osteoarthritis".

3. Obstetrics and Gynecology - Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife-CSD) in the treatment of uterine traumatic healing.